Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fondation Hôpital Saint-Joseph
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient whose age is ≥ 18 years
Patient with histologically proven pancreatic adenocarcinoma (biopsy or resection specimen)
Non-metastatic (M0) on the PCR form
Patient who received chemotherapy or radio-chemotherapy first
MRI and CT scans performed before or at the beginning of neo-adjuvant (or induction) treatment, during treatment and/or at the end of neo-adjuvant treatment (but before excision surgery)
French-speaking patient
You may not be if
Patients who object to the use of their data for this research
Patients operated on immediately without neoadjuvant treatment
Patients for whom re-evaluation MRI or CT is not available or has not been done
Patients for whom the re-evaluation MRI or CT scan was performed more than 60 days before surgery.
Clareo Health | Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRI
